GH Research Reports First Quarter 2024 Financial Results and Provides Business Updates
Phase 2b clinical trial of GH001 in patients with treatment-resistant depression on track for expected completion of double-blind phase in […]
Uniti to Merge with Windstream Creating Premier Insurgent Fiber Provider
Scaled Platform and Differentiated Focus on Tier II and III Markets De-levered Balance Sheet and Cash Flow Generation to Support […]
Rapid Micro Biosystems Reports First Quarter 2024 Financial Results
Reports first quarter 2024 total revenue of $5.6 million, representing growth of 11% compared to first quarter 2023 Reaffirms full […]
Galera Adopts Limited Duration Stockholder Rights Agreement
MALVERN, Pa., May 03, 2024 (GLOBE NEWSWIRE) — Galera Therapeutics, Inc. (Nasdaq: GRTX), a biopharmaceutical company focused on developing a […]
Plug Signs MOU with Allied Green Ammonia for 3GW of Electrolyzer Supply at World-Class Green Ammonia Production Facility
LATHAM, N.Y., May 03, 2024 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions […]
Balchem Corporation Reports First Quarter 2024 Financial Results
MONTVALE, N.J., May 03, 2024 (GLOBE NEWSWIRE) — Balchem Corporation (NASDAQ: BCPC) reported today financial results for its 2024 fiscal […]
BeyondSpring To Host Virtual R&D Day to Discuss New Plinabulin Development Strategy for Cancer and Updates for SEED Therapeutics
FLORHAM PARK, N.J., May 03, 2024 (GLOBE NEWSWIRE) — BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage global […]
ECARX Releases Multiple Intelligent Driving Features for Skyland Pro
SHANGHAI, China, May 03, 2024 (GLOBE NEWSWIRE) — ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a global mobility […]
Werewolf Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
— Company to present an update of its ongoing monotherapy and combination Phase 1/1b trial of WTX-124 in advanced or […]
Agios to Present at the RBC Capital Markets Global Healthcare Conference on May 14, 2024
CAMBRIDGE, Mass., May 03, 2024 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK […]
